Experimental Section
mixture to yield (Z)-(4-chloro-1-(4-methoxyphenyl)but-1-ene-1,2-diyl)dibenzene4or (Z)-2-(4-(4-chloro-1,2-diphenylbut-1-en-1-yl)phenoxy)ethan-1-ol 5respectively.
General Procedure for the synthesis of (Z)-(4-azido-1-(4-methoxyphenyl)but-1-ene-1,2diyl)dibenzene 6 and (Z)-2-(4-(4-azido-1,2-diphenylbut-1-en-1-yl)phenoxy)ethan-1-ol 7:
To the stirred solution of (Z)-(4-chloro-1-(4-methoxyphenyl)but-1-ene-1,2-diyl)dibenzene4or (Z)-2-(4-(4-chloro-1,2-diphenylbut-1-en-1-yl)phenoxy)ethan-1-ol 5indry DMF was added sodium azide(1.2 mmol). The reaction mixture was allowed to stir at 60  Cfor 4 h. The progress of reaction mixture was monitored via TLC. After usual work up with ethyl acetate and water, the organic layers were combined, dried over anhydrous Na 2 SO 4 and evaporated under reduced pressure to yield white colour solid, 6 or 7 respectively. General Procedure for the synthesis ofO-methylated Ospemifene-isatin/isatin-spiroketal conjugates 12 and 13:To the stirred solution of (Z)-(4-azido-1-(4-methoxyphenyl)but-1-ene-1,2-diyl)dibenzene6andN-alkylazido-isatin10 (1 mmol) or N-alkylazidospiro-isatin11(1 mmol)in ethanol: water (85:15) mixture, was added CuSO 4 .5H 2 O (0.055 mmol) and sodium ascorbate (0.143 mmol). The reaction mixture was allowed to stir at room temperature for 6-8 h, with progress monitored via TLC. On completion, the reaction mixture was extracted with ethyl acetate and water and the combined organic layers were dried over anhydrous Na 2 SO 4 and concentrated under vacuum to afford the desired conjugate which was purified via column chromatography using ethyl acetate: hexane (60:40) mixture. 5,7-dibromo-1-((1-(4-(4-(2-hydroxyethoxy)phenyl)-3,4-diphenylbut-3-en-1-yl)-1H-1,2,3-triazol-4-yl) 1-((1-(4-(4-(2-hydroxyethoxy)phenyl)-3,4-diphenylbut-3-en-1-yl)-1H-1,2,3- 1-((1-(4-(4-(2-hydroxyethoxy)phenyl)-3,4-diphenylbut-3-en-1-yl)-1H-1,2,3- 1-((1-(4-(4-(2-hydroxyethoxy) 1-((1-(4-(4-(2-hydroxyethoxy) 1-((1-(4-(4-(2-hydroxyethoxy) 1-((1-(4-(4-(2-hydroxyethoxy) 1-((1-(4-(4-(2-hydroxyethoxy) 
(Z)-1-((1-(4-(4-methoxyphenyl)-3,4-diphenylbut-3-en-1-yl)-1H-1,2,3-triazol-4yl)methyl)indoline-2,3-dione (12a):

(Z)-5-fluoro-1-((1-(4-(4-methoxyphenyl)-3,4-diphenylbut-3-en-1-yl)-1H-1,2,3-triazol-4yl)methyl)spiro[indoline-3,2'-[1,3]dioxolan]-2-one (13b):Yield
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